Associated Papers
Clinically Defined Mutations in MEN1 Alter Its Tumor-suppressive Function Through Increased Menin Turnover.
Duan S et al.
Cancer Research Communications, 2023
Menin Loss in Pheochromocytoma of Multiple Endocrine Neoplasia Type 1.
Asa SL et al.
Endocrine Pathology, 2023
Multiple endocrine neoplasia type 1 familial case in a patient with insulinoma and primary hyperparathyroidism: First report in literature and in the Costa Rican population of the c.1224_1225insGTCC pathogenic variant.
Molina-Céspedes P et al.
Clinical Case Reports, 2023
Convergence between germline and somatic mutations in pancreatic neuroendocrine tumors.
Ling C et al.
European Journal of Endocrinology, 2022
SWI/SNF complex alterations as a biomarker of immunotherapy efficacy in pancreatic cancer.
Botta GP et al.
Jci Insight, 2021
34375311 (PubMed )
Supplement: jciinsight-6-150453-s258.pdf
Microsatellite Instability-High, Malignant Insulinoma With Brain Metastasis.
Starr J et al.
Cureus, 2021
Exome sequencing and characterization of 49,960 individuals in the UK Biobank.
Van Hout CV et al.
Nature, 2020
33087929 (PubMed )
Supplement: 41586_2020_2853_MOESM11_ESM.xlsx › Sheet1
Genes involved in angiogenesis and mTOR pathways are frequently mutated in Asian patients with pancreatic neuroendocrine tumors.
Chou WC et al.
International Journal of Biological Sciences, 2016
27994516 (PubMed )
Supplement: ijbsv12p1523s1.xls › mutation_table
Primary hyperparathyroidism in MEN1 patients: a cohort study with longterm follow-up on preferred surgical procedure and the relation with genotype.
Pieterman CR et al.
Annals of Surgery, 2012
Clinical testing for multiple endocrine neoplasia type 1 in a DNA diagnostic laboratory.
Klein RD et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics, 2005
Select a paper to view details